CARBOSYNTH

Serial Number 88471439
Registration 5994650
700

Registration Progress

Application Filed
Jun 13, 2019
Under Examination
Approved for Publication
Dec 10, 2019
Published for Opposition
Dec 10, 2019
Registered
Feb 25, 2020

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2020-02-25)
Due: Feb 25, 2026 232 days

Basic Information

Serial Number
88471439
Registration Number
5994650
Deadline
February 25, 2026
Description
5 Year - Section 8 and 15 Renewal
Filing Date
June 13, 2019
Registration Date
February 25, 2020
Published for Opposition
December 10, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 25, 2020
Registration
Registered
Classes
001 005

Rights Holder

Biosynth AG

03
Address
P.O. Box 125
Staad 9422
CH

Ownership History

Biosynth AG

Original Applicant
03
Staad CH

Biosynth AG

Owner at Publication
03
Staad CH

Biosynth AG

Original Registrant
03
Staad CH

Legal Representation

Attorney
Tara Sliva

USPTO Deadlines

Next Renewal Deadline
232 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-02-25)
Due Date
February 25, 2026
Grace Period Ends
August 25, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

19 events
Date Code Type Description
Feb 25, 2025 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Aug 18, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 18, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 18, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 25, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER
Dec 10, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 10, 2019 PUBO A PUBLISHED FOR OPPOSITION
Nov 20, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 7, 2019 ALIE A ASSIGNED TO LIE
Nov 4, 2019 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 31, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 30, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 30, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 5, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 5, 2019 GNRT F NON-FINAL ACTION E-MAILED
Sep 5, 2019 CNRT R NON-FINAL ACTION WRITTEN
Sep 5, 2019 DOCK D ASSIGNED TO EXAMINER
Jun 25, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 17, 2019 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 001
Biochemicals and organic chemicals used as enzyme substrates, enzyme inducers, namely, aminoglutethimides, carbamazepines, griseofulvins, and primidones, enzyme inactivators, or cultural medium additives for use in the field of microbiology and molecular biology; biochemical and organic chemical reagents for clinical diagnostic laboratory use; biochemical and organic chemicals for use in the manufacture of pharmaceuticals and cosmetics; ; Chemical reagents for medical research use in the field of immunology; Chemical reagents for medical laboratory analysis purposes, namely, for use as a routine medical supplement to blood culture media in vitro to inhibit blood coagulation and to improve the detection limits for individual microorganisms
First Use Anywhere: May 14, 2012
First Use in Commerce: May 14, 2012
Class 005
Medicinal preparations, namely, photosensitizing agents used as a dermatologic drug for the treatment of skin cancer by phototherapy; Chemical reagents for medical or veterinarian use; Chemical reagents for use as culture media for cultures of microorganisms for medical use, namely, for the isolation and identification of the bacteria strain Escherichia coli O157:H7; Chemical preparations for medical purposes, namely, for Cholesterol testing to prevent possible consequences of Hypercholesterolemia such as atherosclerosis, coronary heart disease and other forms of cardiovascular diseases; Chemical preparations for medical purposes, namely, for novel enzyme responsive inhibitors that allow for modifications of the composition of microbial communities; Organic chemical preparations for medical purposes, namely, immunomodulators with anti-inflammatory properties; Organic chemical preparations and enzymes for medical laboratory analysis purposes, namely, for medical detection, identification and quantification of strains of pathogenic bacteria; Chemical preparations for medical laboratory analysis purposes, namely, for medical immunological and microbiological blood testing; Chemical preparations for medical laboratory analysis purposes, namely, for medical detection of pathogenic bacteria, namely, various strains of Listeria, Clostridium, Bacillus and Staphylococcus; Chemical preparations for medical laboratory analysis purposes, namely, for the medical detection and quantification of bacteria strains of Escherichia coli; Medical preparations for the diagnosis of Staphylococus aureus, in particular for Methicillin-resistant Staphylococcus aureus (MRSA)
First Use Anywhere: May 14, 2012
First Use in Commerce: May 14, 2012

Classification

International Classes
001 005